Salud financiera de hoja de balance de China Biotech Services Holdings
Salud financiera controles de criterios 2/6
China Biotech Services Holdings tiene un patrimonio de los accionistas total de HK$381.3M y una deuda total de HK$155.1M, lo que sitúa su ratio deuda-patrimonio en 40.7%. Sus activos y pasivos totales son HK$630.6M y HK$249.2M respectivamente.
Información clave
40.7%
Ratio deuda-patrimonio
HK$155.09m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | HK$33.24m |
| Patrimonio | HK$381.32m |
| Total pasivo | HK$249.23m |
| Activos totales | HK$630.55m |
Actualizaciones recientes sobre salud financiera
Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?
Dec 09
These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely
Aug 24Is China Biotech Services Holdings (HKG:8037) A Risky Investment?
Oct 13Recent updates
China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk
Aug 12Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio
Jun 26China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%
Mar 07Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%
Jan 18We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger
Jan 06Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?
Dec 09These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely
Aug 24A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)
Nov 05Is China Biotech Services Holdings (HKG:8037) A Risky Investment?
Oct 13What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You
Jun 28China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger
Mar 16China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively
Dec 01Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive
Jul 26China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors
Apr 05Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital
Mar 23Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?
Feb 23Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)
Jan 28
What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?
Jan 11The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested
Dec 08Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (HK$157.1M) de 8037 no cubren sus pasivos a corto plazo (HK$211.5M).
Pasivo a largo plazo: Los activos a corto plazo de 8037 (HK$157.1M) superan a sus pasivos a largo plazo (HK$37.7M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (32%) de 8037 se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de 8037 ha crecido de 2.8% a 40.7% en los últimos 5 años.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: Datos insuficientes para determinar si 8037 tiene suficiente cash runway basado en su flujo de caja libre actual.
Pronóstico de cash runway: Datos insuficientes para determinar si 8037 tiene suficiente cash runway en caso de que su flujo de caja libre siga creciendo o disminuyendo basado en tasas históricas.